Basit öğe kaydını göster

dc.contributor.authorBelli, A.A.
dc.contributor.authorGok, S.O.
dc.contributor.authorAkbaba, G.
dc.contributor.authorEtgu, F.
dc.contributor.authorDogan, G.
dc.date.accessioned2020-11-20T16:47:58Z
dc.date.available2020-11-20T16:47:58Z
dc.date.issued2016
dc.identifier.issn1167-1122
dc.identifier.urihttps://doi.org/10.1684/ejd.2016.2748
dc.identifier.urihttps://hdl.handle.net/20.500.12809/5957
dc.descriptionPubMed ID: 27328660en_US
dc.description.abstractBackground: Rosacea is a chronic inflammatory skin disease affecting the face. A positive correlation has been found between rosacea and cardiovascular diseases. Objectives: We sought to investigate the relation between rosacea and metabolic syndrome (MS) and insulin resistance (IR). Materials and methods: Between January and June 2015, a case-control study including 47 age-, gender-, and body mass index (BMI)-matched rosacea patients and 50 controls was conducted. Demographic data, clinical features of rosacea patients, anthropometric measures, laboratory findings, blood pressure levels, BMI, smoking history, alcohol consumption, sports life, family history of cardiovascular disease, and presence of MS and IR were recorded. Results: Forty-seven rosacea patients (12 men and 35 women; age range: 35-68 years) and 50 controls (11menand 39women; age range: 38-78 years) were included in our study. Of 47 rosacea patients, 24 had erythematotelangiectatic type, 22 had papulopustular type, and one had phymatous type. Whereas the rate of IR was significantly higher in the rosacea group, there was no significant difference in the rate of MS between rosacea and the control group (p = 0.009 and p = 0.186, respectively). In addition, the rosacea group had significantly higher fasting blood glucose, total cholesterol, and systolic and diastolic blood pressure levels (p<0.05). Mean levels of LDL, triglyceride, total cholesterol and CRP were significantly higher than in the control group (p<0.05). Conclusion: Our findings suggest that there is a relationship between rosacea and IR and some parameters of cardiovascular risk factors.We recommend investigation of IR in rosacea patients. © 2016 John Libbey Eurotext.en_US
dc.item-language.isoengen_US
dc.publisherJohn Libbey Eurotexten_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCardiovascular diseasesen_US
dc.subjectInsulin resistanceen_US
dc.subjectMetabolic syndromeen_US
dc.subjectRosaceaen_US
dc.titleThe relationship between rosacea and insulin resistance and metabolic syndromeen_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTempBelli, A.A., Department of Dermatology, Kocman University Training, Research HospitalMugla, Turkey; Gok, S.O., Department of Dermatology, Artvin Hopa State Hospital, Artvin, Turkey; Akbaba, G., Department of Endocrinology and Metabolism Diseases, Mugla Sitki Kocman University Training and Research HospitalMugla, Turkey; Etgu, F., Ardahan State Hospital, Department of Dermatology, Ardahan, Turkey; Dogan, G., Department of Dermatology, Kocman University Training, Research HospitalMugla, Turkeyen_US
dc.identifier.doi10.1684/ejd.2016.2748
dc.identifier.volume26en_US
dc.identifier.issue3en_US
dc.identifier.startpage260en_US
dc.identifier.endpage264en_US
dc.relation.journalEuropean Journal of Dermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster